Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5660 of 5804
-
New COPD drug candidate AN01 begins first human safety tests
Knowledge-focused Recruiting nowAN01 is a selective small-molecule dual inhibitor of phosphodiesterase 3 and 4 (PDE3/4). As a potential new therapy for COPD, AN01 is expected to serve either as a monotherapy for COPD or as adjunctive therapy to current inhaled standard treatments, potentially generating synerg…
Phase: PHASE1 • Sponsor: AirNexis Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Blood test could spot hidden cancer cells after breast cancer surgery
Knowledge-focused TerminatedThis clinical trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) based minimal residual disease (MRD) detection works for patients with early-stage breast cancer. MRD refers to a very small number of tumor cells that remain in the body during or after treatmen…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New tampon safety checked in 60 women
Symptom relief Recruiting nowThe goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.
Phase: NA • Sponsor: Kimberly-Clark Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Healthy volunteers test two versions of experimental drug
Knowledge-focused OngoingThis study will compare the pharmacokinetics (PK) effect of two different formulations of Gecacitinib Hydrochloride Tablets in healthy Adult participants
Phase: PHASE1 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New drug NHL907 tested for safety in healthy people
Knowledge-focused Recruiting nowThe goal of this study is to evaluate the safety, tolerability and pharmacokinetics of NHL907 when administered as multiple oral doses in healthy adult participants.
Phase: PHASE1 • Sponsor: NeuHyll AUS Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Healthy volunteers help test new drug formulation
Knowledge-focused OngoingThe objective of this study is to evaluate the pharmacokinetics (PK) and relative bioavailability of emraclidine following single oral administration of different immediate-release (IR) tablet formulations in healthy adult participants.
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New HIV drug MK-4646 put through safety check in healthy volunteers
Knowledge-focused OngoingResearchers are looking for new treatments for people living with HIV-1(Human Immunodeficiency Virus Type 1). HIV-1 is the most common type of HIV, which is a virus that attacks cells of the immune system. HIV-1 treatments, called ART (antiretroviral therapy), involve taking med…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Meal timing matters: new study tests drug absorption after eating
Knowledge-focused Recruiting nowThis study is a single-center, randomized, open label, 3×3 crossover design to assess the high-fat meal and the standard meal effects on PK of a single oral dose of VV913 in healthy adult volunteers.
Phase: PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Food dye skin test pulled before it even started
Knowledge-focused TerminatedThe goal of this clinical trial is to learn if the topical application of tartrazine, an FDA-approved food dye, can help improve the transparency of the skin in healthy volunteers. The main questions it aims to answer are: * Can topical tartrazine application allow for temporary…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Can Quick-Trained operators get accurate heart ultrasound readings?
Knowledge-focused Recruiting nowHealthy subjects will have transthoracic echocardiography evaluation of Left Ventricular Outflow Tract Velocity-Time Integral (LVOT VTI) performed by operators after brief training.
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New tafamidis tablet could be easier to swallow
Knowledge-focused OngoingThe purpose of this clinical trial is to compare the blood tafamidis concentration of healthy adult participants after taking two different forms of tafamidis by under fasted conditions.
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New antibody BCD-261 put to the test in healthy volunteers
Knowledge-focused OngoingThe goal of this study is to evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 after Single Subcutaneous Injection in Healthy Chinese Volunteers
Phase: PHASE1 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New diabetes drug combo tested in humans for first time
Knowledge-focused OngoingThis is a randomized, open, single-dose, crossover-design, phase I study to evaluate the pharmacokinetics and safety after co-administration of L03RD1 and L03RD2 or administration of L03TD1 in healthy volunteers.
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Pfizer tests new drug in healthy volunteers – first human doses underway
Knowledge-focused CompletedThe purpose of this clinical trial is to learn about the safety and pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from body after participant take it) of the study medicine (called PF-08057418) in healthy people. This study is seek…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Healthy volunteers needed to test two versions of migraine medicine
Knowledge-focused Recruiting nowThe purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Healthy men to test two insulin shots in Early-Stage study
Knowledge-focused Recruiting nowThis study is a Phase I clinical trial that uses positive glucose clamping technology to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence of IBI3035 with insulin injection (Awiqli?) after a single administration in healthy male subjects
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New pain drug tested with HIV pill in healthy volunteers
Knowledge-focused OngoingThe purpose of the study is to evaluate the pharmacokinetics (PK) of Suzetrigine (SUZ) and its metabolite in the absence and presence of efavirenz, a moderate CYP3A inducer. In addition, the purpose is to evaluate the safety and tolerability of SUZ when administered in the absenc…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New drug REGN22044 tested in people for the first time
Knowledge-focused Not yet recruitingThis clinical study will evaluate the study drug, REGN22044, in healthy participants. REGN22044 has not previously been studied in humans. The purpose of this study is to learn: * What side effects may happen when REGN22044 is taken * How much of REGN22044 is in the blood at di…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New drug LY4302814 tested in healthy volunteers for first time
Knowledge-focused Recruiting nowThe main purpose of this study is to assess how well LY4302814 is tolerated and what side effects may occur in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. For each participant, t…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Music festival anxiety study pulled before it began
Symptom relief TerminatedThe goal of this clinical trial is to learn about the effect of a sphenopalatine ganglion (SPG) block in anxious patients at electronic dance music festivals. The main question is: \- Is an SPG block useful in reducing anxiety, in comparison to placebo? Participants will have l…
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC